Method Article

A Study of the Complexation of Mercury(II) with Dicysteinyl Tetrapeptides by Electrospray Ionization Mass Spectrometry

DOI:

10.3791/53536

January 8th, 2016

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The characterization of complexes formed in different relative ratios of mercury(II) to dicysteinyl tetrapeptides by electrospray ionization orbitrap mass spectrometry is presented.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

In this study we evaluated a method for the characterization of complexes, formed in different relative ratios of mercury(II) to dicysteinyl tetrapeptide, by electrospray ionization orbitrap mass spectrometry. This strategy is based on previous successful characterization of mercury-dicysteinyl complexes involving tripeptides by utilizing mass spectrometry among other techniques. Mercury(II) chloride and a dicysteinyl tetrapeptide were incubated in a degassed buffered medium at varying stoichiometric ratios. The complexes formed were subsequently analyzed on an electrospray mass spectrometer consisting of a hybrid linear ion- and orbi- trap mass analyzer. The electrospray ionization mass spectrometry (ESI-MS) spectra were acquired in the positive mode and the observed peaks were then analyzed for distinct mercury isotopic distribution patterns and associated monoisotopic peak. This work demonstrates that an accurate stoichiometry of mercury and peptide in the complexes formed under specified electrospray ionization conditions can be determined by using high resolution ESI MS based on distinct mercury isotopic distribution patterns.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Current clinical drugs prescribed for chelation therapy of mercury poisoning1 contain thiol group(s), which is/are responsible for binding and sequestering mercury ions2,3. However, studies have shown that these small thiol compounds [dimercaptosuccinic acid (DMSA) and dimercaptopropane-sulfonic acid (DMPS)] are not optimal for mercury chelation therapy4-6. Therefore, there is a need to understand the association and complex formation tendencies of mercury with thiols to enhance the rational drug design of thiol compounds for mercury chelation. Recently, we reported that n-alkyl and aryl dicysteinyl tripeptides with dithiol groups can serve as effective "double anchors" to accommodate the coordination sites of mercury(II) to form 1:1 mercury(II):peptide and 1:2 mercury(II):(peptide)2 complexes7. Additionally, we studied the effect of increasing cysteinyl residues on complex type formations8. In this study, we investigate the association of mercury(II) with two dicysteinyl tetrapeptides, where the cysteinyl residues are separated by two amino acid residues. In order to evaluate the effect of auxiliary binding groups for mercury, the intervening amino acids are either two glycine (unsubstituted) residues or two glutamic acid (gamma-carboxylated) residues.

The reaction of cysteinyl peptide with mercury(II) requires conditions that will prevent the oxidation of the cysteinyl thiol groups to form disulfide bonds9. Moreover, the association of mercury(II) with cysteinyl peptides to form various types of mercury-peptide complexes is dependent on the initial ratio of mercury(II): peptide in the reaction mixture7,8. The types of mercury-peptide complexes formed in these reaction mixtures can be analyzed by soft-ionization mass spectroscopy, which is a sensitive analytical tool for determining species interactions between metal ions and peptides10-14. Accordingly, it will provide a profile of the various types of mercuriated peptide adducts that are formed under a specified electrospray ionization condition. Here, we will show how cysteinyl peptides and mercury(II) chloride solutions can be prepared in degassed ammonium formate buffer solution blanketed with argon to minimize oxidation. By reacting varying mole equivalents of mercury(II) with dicysteinyl tetrapeptides, we will show how the initial ratio of mercury(II):peptide has an effect on the types of complexes formed. We will also show how electrospray ionization (ESI) mass spectrometry can be used as a characterization tool to provide an accurate stoichiometry of mercury to peptide in the complexes formed. The associated video protocol will demonstrate the experimental conditions for preparing the mercury complexes, the procedure for analyzing the reaction mixtures under specified electrospray ionization conditions, and the characterization of the stoichiometries of mercury(II)-dicysteinyl tetrapeptide complexes, based on the distinct mercury isotope distribution patterns, by using the ChemCal program15. It is intended to assist those who are interested in using ESI orbitrap mass spectrometry to analyze various complexes formed by metal ions that exist in different isotopic forms.

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Note: Please consult all relevant material safety data sheets (MSDS) before use. Mercury chloride is a toxic chemical. Personal protective equipment (gloves, safety goggles, and lab coat) must be worn when handing it and all associated solutions. Dispose of solutions in clearly labeled chemical waste bottles designated for heavy metals.

1. Preparation of 5 mM Degassed Ammonium Formate Buffer, pH 7.5

  1. Dissolve 0.1576 g of ammonium formate buffer in 450 ml of HPLC grade water. Adjust the pH of the above solution with 1 M formic acid and 1 M ammonium hydroxide to 7.5. Transfer this solution to a 500 ml volumetric flask and add HPLC water to the calibration line to make a 5 mM ammonium formate solution.
  2. Degas the 5 mM ammonium formate buffer under a vacuum system for 10 min and purge with argon. Repeat twice and store solution under argon. On the day of use, filter the buffer solution through a 0.2 micron filter before use.

2. Preparation of Mercury(II) Chloride Solutions

  1. Weigh out 0.2375 g mercury(II) chloride. Dissolve it in 25 ml of 5 mM ammonium formate buffer to produce a 0.035 M mercury(II) chloride solution.
  2. Add 0.214 ml of 0.035 M mercury(II) chloride solution to 9.785 ml of 5 mM ammonium formate buffer to create a 7.5 x 10-4 M solution. Blanket the 7.5 x 10-4 M mercury(II) solution with argon gas.

3. Preparation of CGGC Stock Solution

  1. Dissolve 2.0 mg of the dicysteinyl tetrapeptide, CGGC, in 0.118 ml of HPLC grade acetonitrile and then add 1.0647 ml of 5 mM ammonium formate, pH 7.5 buffer that has been degassed in argon to yield a 5 mM CGGC stock solution.
  2. Add 225 µl of the 5 mM CGGC stock solution to 1,275 µl of 5 mM ammonium formation pH 7.5 buffer to give a 7.5 x 10-4 M CGGC solution.

4. Preparation of Various Reaction Mixtures of Mercury(II) and CGGC

  1. Preparation of 1:0.5 ratio of mercury(II):CGGC solution
    1. Place 255 µl of 5 mM ammonium formate, pH 7.5 buffer into a 1.5 ml microcentrifuge tube. Add 30 µl of 7.5 x10-4 M mercury(II) chloride solution into the 1.5 ml microcentrifuge tube with the ammonium formate buffer.
    2. Vortex the solution for 10 sec. Then add 15 µl of 7.5 x 10-4 M CGGC solution into the 1.5 ml microcentrifuge. Vortex the solution for 10 sec. Let the solution stand for 10 min prior to injection into the mass spectrometer.
  2. Preparation of 1:1 ratio of mercury(II):CGGC solution
    1. Place 240 µl of 5 mM ammonium formate, pH 7.5 buffer into a 1.5 ml microcentrifuge tube. Add 30 µl of 7.5 x10-4 M mercury(II) chloride solution into the 1.5 ml microcentrifuge tube with the ammonium formate buffer.
    2. Vortex the solution for 10 sec. Then add 30 µl of 7.5 x 10 -4 M CGGC solution into the 1.5 ml microcentrifuge tube. Repeat in a similar manner as described in section 4.1.
  3. Preparation of 1:2 ratio of mercury(II):CGGC solution
    1. Place 210 µl of 5 mM ammonium formate, pH 7.5 buffer into a 1.5 ml microcentrifuge tube. Add 30 µl of 7.5 x10-4 M mercury(II) chloride solution into the 1.5 ml microcentrifuge tube with the ammonium formate buffer.
    2. Vortex the solution for 10 sec. Then add 60 µl of 7.5 x 10-4 M CGGC solution into the 1.5 ml microcentrifuge tube. Repeat in a similar manner as described in section 4.1.

5. Preparation of CEEC Stock Solution

  1. Dissolve 3.5 mg of the dicysteinyl tetrapeptide, CEEC, in 0.145 ml of HPLC grade acetonitrile to dissolve the peptide. Then add 13.067 ml of 5 mM ammonium formate, pH 7.5 buffer that has been degassed in argon to produce 0.5 mM CEEC solution.
  2. Vortex the solution until all peptide is dissolved. Add 1.125 ml of 0.5 mM CEEC solution and 0.375 ml of 5 mM ammonium formate, pH 7.5 buffer to a 1.5 ml microcentrifuge tube to give a 7.5 x 10-5 M CEEC solution. Vortex until mixed.

6. Preparation of Various Reaction Mixtures of Mercury(II) and CEEC Solution

  1. Preparation of 1:0.5 ratio of mercury(II):CEEC solution
    1. Place 255 µl of 5 mM ammonium formate, pH 7.5 buffer into a 1.5 ml microcentrifuge tube. Add 30 µl of 7.5 x10-4 M mercury(II) chloride solution into the 1.5 ml microcentrifuge tube with the ammonium formate buffer.
    2. Vortex the solution for 10 sec. Then add 15 µl of 7.5 x 10-4 M CEEC solution into the 1.5 ml microcentrifuge tube. Repeat in a similar manner as described in section 4.1.
  2. Preparation of 1:1 ratio of mercury(II):CEEC solution
    1. Place 240 µl of 5 mM ammonium formate, pH 7.5 buffer into a 1.5 ml microcentrifuge tube. Add 30 µl of 7.5 x10-4 M mercury(II) chloride solution into the 1.5 ml microcentrifuge tube with the ammonium formate buffer.
    2. Vortex the solution for 10 sec. Then add 30 µl of 7.5 x 10-4 M CEEC solution into the 1.5 ml microcentrifuge tube. Repeat in a similar manner as described in section 4.1.
  3. Preparation of 1:2 ratio of mercury(II):CEEC solution
    1. Place 210 µl of 5 mM ammonium formate, pH 7.5 buffer into a 1.5 ml microcentrifuge tube. Add 30 µl of 7.5 x10-4 M mercury(II) chloride solution into the 1.5 ml microcentrifuge tube with the ammonium formate buffer.
    2. Vortex the solution for 10 sec. Then add 60 µl of 7.5 x 10-4 M CEEC solution into the 1.5 ml microcentrifuge tube. Repeat in a similar manner as described in section 4.1.

7. Analyzing the Reaction Mixtures of Mercury(II) and CGGC Samples by Orbitrap ESI Mass Spectrometry

  1. Preparing the ESI mass spectrometer16
    1. Draw 100 µl of calibration standards into a 500 µl glass syringe.
    2. Place the syringe in the syringe cradle of the MS pump, attach the tubing, and inject into the mass spectrophotometer.
    3. Set up the file name for the run by selecting the file icon and typing the file name.
    4. Select acquire data button in the data acquisition module and collect 150 scans.
    5. Analyze the chromatogram to verify the calibration standards by opening data processing module of the software. Open the module, go to file menu and select "open", and select the file in the dialog box. Verify that the peaks in the chromatogram correlate to the mass to charge ratios of the standards.
    6. Clean the 500 µl glass syringe by drawing up 500 µl HPLC grade methanol and then dispense the methanol into a beaker.
    7. Draw up 500 µl of HPLC grade methanol into the glass syringe and flush the system as per step 7.1.2.
    8. Select the method setup module of the software to set the parameters. Choose the scan mode menu and identify the analyzer as FTMS, and then click on "OK". Then by clicking on the various icons on the real-time view spectrum page, set the following parameters: Sheath gas flow rate: 10, Source temperature: 0, Capillary voltage: 37 V, Tube lens: 95 V, Spray voltage: 4.20 kV, Flow rate 10.00 µl/min, Analyzer: FTMS, Number of scans: 150.
  2. Running CGGC samples on ESI mass spectrometer
    1. Run the 5 mM ammonium formate pH 7.5 buffer.
      1. Place 500 µl of 5 mM ammonium formate buffer into the 500 µl glass syringe, place it into the syringe cradle of the MS pump, and attach the tubing.
      2. Run buffer through the tubing for 1-2 min.
      3. Set up the file name for the run by selecting the file icon and typing the file name.
      4. Select acquire data button in the module and collect 150 scans.
      5. Click the run button to stop collection after 150 scans are collected.
      6. Open the data browser module, then go to file menu and select "open", and select the file in the dialog box. Verify that no peaks at 483, 683, 1,163 and 1,363 m/z are present that resemble the peptide or mercury (II)-peptide complexes.
    2. Run the 1:0.5 mercury(II):CGGC ratio solution.
      1. Place 250 µl of 1:0.5 mercury(II):CGGC ratio of the sample into the syringe.
      2. Place the syringe into the syringe cradle of the MS pump, attach the tubing, and prime the apparatus.
      3. Select a file name for the run by selecting the file icon and typing the file name.
      4. Press the acquire data button in the data acquisition module and collect 150 scans and click the run button to stop the collection.
      5. Open the module, go to file menu and select "open", and select the file in the dialog box. Verify that the chromatogram contains peaks including the one for the CGGC peptide alone.
      6. Wash the syringe by aspirating with 500 µl ammonium formate buffer and then dispensing the ammonium formate buffer into a beaker.
      7. Select the waste button on the MS and flush the tubing three times with 500 µl ammonium formate buffer.
      8. Wash the syringe by aspirating with 500 µl methanol and then dispensing the methanol into a beaker.
      9. Flush the tubing one time with 500 µl methanol.
      10. Select load detector button on the MS.
      11. Add 500 µl of ammonium formate buffer to the syringe.
      12. Place the syringe into the syringe cradle of the MS pump, attach the tubing, and prime the apparatus.
      13. Select a file name for the buffer run by selecting the file icon and typing the file name.
      14. Press the acquire data button and collect 150 scans and then click the stop run button.
      15. Open the data browser module, go to file menu and select "open", and select the file in the dialog box. Verify that the chromatogram is void of peaks from the previous Hg:CGGC run.
    3. Run the 1:1 mercury(II):CGGC ratio solution.
      1. Place 250 µl of 1:1 mercury(II):CGGC ratio sample into the syringe.
      2. Repeat in a similar manner as described for Steps 7.2.2.2 to 7.2.2.15.
    4. Run the 1:2 mercury(II):CGGC ratio solution
      1. Place 250 µl of 1:2 mercury(II):CGGC concentration sample into the syringe.
      2. Repeat in a similar manner as described for Steps 7.2.2.2 to 7.2.2.15.

8. Analyzing the Reaction Mixtures of Mercury and CEEC Samples by Orbitrap ESI Mass Spectrometry

  1. Running CEEC samples on ESI mass spectrometer
    1. Repeat analysis procedure (Steps 7.1 to 7.2) using CEEC samples and reaction mixtures of mercury(II) and CEEC at various stoichiometric ratios.

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

A study was performed to characterize the possible mercury-peptide complex composition for two tetrapeptides, CGGC and CEEC (Figure 1) by ESI mass spectrometry. Complexes of mercury(II) with CGGC or CEEC were investigated by reacting the mixtures of mercury(II) and peptide solutions at three different molar ratios: 1:0.5, 1:1, and 1:2 (mercury(II): peptide). The concentration of mercury(II) was 7.5 x 10-6 M and the peptide concentration varied accordingly.

...

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The hydrophobic dicysteinyl tetrapeptide CGGC (C10H18N4O5S2; MW = 338) (Figure 1), forms complexes with mercury(II) as shown in Figure 2 and Table 1. Additionally, it forms peptide dimers and trimers incrementally as the amount of peptide increases in the reaction mixture. As shown by the m/z values of the associated dimers [(2M+H)+ = 677] and trimers [(3M+H)+ = 1015], the thiol groups of CGGC d...

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

There is no disclosure for the work reported.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

M.N-S acknowledges support from the National Science Foundation, RUI grant CHE 1011859. The authors gratefully acknowledge the Triad Mass Spectrometry Facility at the University of North Carolina at Greensboro for use of the Thermo Fisher Scientific LTQ Orbitrap XL mass spectrometer. The authors thank Daniel Todd, Vincent Sica, and Brandie Erhmann at the University of North Carolina at Greensboro for helpful suggestions and comments regarding this work.

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Mercury(II) chlorideSigma-Aldrich429724Highly toxic
Ammonium formateSigma-Aldrich516961
Formic acidSigma-AldrichF0507
Ammonium hydroxideFisherA512-P500
HPLC waterFisherW5-4
HPLC AcetonitrileFisherBP2405-1
HPLC MethanolFisherA452-4

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Clifton, J. C. Mercury exposure and public health. Pediatr. Clin. N. Am. 54, 237-269 (2007).
  2. Andersen, O. Principles and Recent Developments in Chelation Treatment of Metal Intoxication. Chem. Rev. 99, 2683-2710 (1999).
  3. Aposhian, H. V., Maiorino, R. M., Gonzalez-Ramirez, D., Zuniga-Charles, M., Xu, Z., Hurlbut, J. M., Junco-Munoz, P., Dart, R. C., Aposhian, M. M. Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology. 97, 23-38 (1995).
  4. Flora, S. J. S., Pachauri, V. Chelation in Metal Intoxication. Int. J. Environ. Res. Public Health. 7, 2745-2788 (2010).
  5. Campbell, J. R., Clarkson, T. W., Omar, M. D. The therapeutic use of 2,3-dimercaptopropane-1-sulfonate in two cases of inorganic mercury poisoning. JAMA. 256, 3127-3130 (1986).
  6. Rooney, J. P. K. The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology. 234, 145-156 (2007).
  7. Lin, X., Brooks, J., Bronson, M., Ngu-Schwemlein, M. Evalution of the association of mercury (II) with some dicysteinyl tripeptides. Bioorg. Chem. 44, 8-18 (2012).
  8. Ngu-Schwemlein, M., Lin, X., Rudd, B., Bronson, M. Synthesis and ESI mass spectrometric analysis of the association of mercury(II) with multi-cysteinyl peptides. J. Inorg. Biochem. 133, 8-23 (2014).
  9. Winther, J. R., Thorpe, C. Quantification of thiols and disulfides. Biochimica et. Biophysica Acta. 1840, 838-846 (2014).
  10. D'Agstino, A., Colton, R., Traeger, J. C., Cantry, A. J. An Electrospray Mass Spectrometric Study of Organomercury (II) and Mercuric Interactions with Peptides Involving Cysteinyl Ligands. Eur. Mass Spectrom. , 273-285 (1990).
  11. Hofstadler, S. A., Sannes-Lowery, K. A. Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes. Nature Reviews Drug Discovery. 5, 585-595 (2006).
  12. Rubino, F. M., Verduci, C., Giampiccolo, R., Pulvirenti, S., Brambilla, G., Columbi, A. Molecular Characterization of Homo- and Heterodimeric Mercury (II)-bis-thiolates of Some Biologically Relevant Thiols by Electrospray Ionization and Triple Quadruple Tandem Mass Spectrometry. J. Am. Soc. Mass Spectrom. 15, 288-300 (2003).
  13. Krupp, E. M., Milne, B. F., Mestrot, A., Meharg, A. A., Feldmann, J. Investigation into mercury bound to biothiols: structural identification using ESI-ion-trap MS and introduction of a method for their HPLC separation with simultaneous detection by ICP-MS and and ESI-MS. Anal. Bioanal. Chem. 390, 1753-1764 (2008).
  14. Schaumlöffel, D., Tholey, A. Recent directions of electrospray mass spectrometry for elemental speciation analysis. Anal. Bioanal. Chem. 400, 1645-1652 (2011).
  15. Patiny, L., Borel, A. ChemCalc: a building block for tomorrow's chemical infrastructure. J. Chem. Inf. Model. 53, 1223-1228 (2013).
  16. Thermo Scientific. Xcaibur Versions 2.1.0-2.3.0 Data Acquisition and Processing User Guide. Revision E. United States. , Thermo Fisher Scientific Inc. (2012).
  17. Falcone, G., Foti, C., Gianguzza, A., Giuffrè, O., Napoli, A., Pettignano, A., Piazzese, D. Sequestering ability of some chelating agents towards methylmercury(II). Anal. Bioanal. Chem. 405 (2), 881-893 (2013).
  18. Mah, V., Jalilehvand, F. Glutathione Complex Formation with Mercury(II) in Aqueous Solution at Physiological pH. Chem. Res. Toxicol. 23, 1815-1823 (2010).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Mercury II ComplexationOrbitrap Mass SpectrometryMercury Isotopic DistributionPeptide Complex AnalysisTandem Mass SpectrometryBuffer DegassingSample PreparationCharge State AnalysisMetal Ion Chelation

Related Articles